Navigation Links
Results of the GIANT trial reported at TCT 2013
Date:11/1/2013

SAN FRANCISCO, CA October 31, 2013 According to a new study, genetic profiling of patients undergoing percutaneous coronary intervention (PCI) may help cardiology teams adjust treatment and improve ischemic outcomes for patients that do not properly metabolize thienopyridine blood thinning therapies such as clopidogrel.

Findings from the GIANT trial were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine.

The effectiveness of clopidogrel depends on activation to an active metabolite, principally via the CYP2C19 enzymatic pathway. Acute coronary syndrome patients that carry a CYP2C19 gene variant poorly metabolize the drug. These patients are known as slow responders and exhibit a higher one year risk of major ischemic events following PCI. Genetic tests can help identify a patient's CYP2C19 genotype, but it is unknown if on-line adjustment of thienopyridine therapy in the genetically slow-responder patient population may counteract this outcome.

The GIANT trial evaluated the clinical impact of CYP2C19 genetic profiling and compliance to an adjusted thienopyridine treatment. The primary endpoint was a composite of death, myocardial infarction, and stent thrombosis after one year in slow responder patients with appropriate therapy after genotyping, compared to non-slow responders.

The prospective, multicenter, single arm study enrolled 1,499 patients at the time of primary PCI (onset chest pain < 24 hours). Genetic profiling was performed within 48 hours after intervention to detect a loss of CYP2C19 gene function and identify a resistance to clopidogrel.

Strong recommendations for treatment adjustment were sent to investigators when patients were identified as slow responders.

Dual antiplatelet
'/>"/>

Contact: Judy Romero
jromero@crg.org
Cardiovascular Research Foundation
Source:Eurekalert

Page: 1 2

Related medicine news :

1. False-Positive Mammogram Results May Turn Out Not to Be: Study
2. Good intentions bring mixed results for Haitis disabled people
3. Presentation of 1-year IVAN and 2-year CATT study results
4. Groundbreaking Nigeria summit results in major commitment to reduce child deaths
5. Surprising results for use of dialysis for kidney failure in developing world
6. Stem Cell Study Shows Promising Results Against Heart Failure
7. Automated insulin dosage titration system demonstrates positive clinical study results
8. Quality of care, other issues may cause worse results in black prostate cancer surgery patients
9. Tight Blood-Sugar Control Shows Mixed Results for Health of Kidneys: Study
10. ACP-New York State Chapter partnership results in patient safety organization recognition
11. Long-term testosterone treatment for men results in reduced weight and waist size
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... Andrzej Klos, M.D., has been reviewed ... pediatrician for nearly 38 years, is motivated each and every day by his sincere ... profession shine alongside his many awards and accolades, which include multiple listings in many ...
(Date:7/29/2015)... ... July 29, 2015 , ... " Core Organizer ” was featured on NewsWatch ... coolest applications on the market for iOS, Android, and Windows. Joe Toohey, the host ... this app will help anyone get organized. , Wouldn’t it be great if everyone ...
(Date:7/29/2015)... ... 29, 2015 , ... The report “Atherosclerosis - Pipeline Review, ... a slow, progressive disease that may start in childhood. The report strengthens R&D ... Complete report on Atherosclerosis Pipeline with 78 market data tables and 15 figures, ...
(Date:7/29/2015)... ... July 29, 2015 , ... Topical BioMedics, Inc., announces it ... and Healing Cream designated as the nonprofit’s natural pain reliever of choice.     ... of Duty Deaths (LODD) and the high rate of pain and injuries firefighters ...
(Date:7/29/2015)... ... July 29, 2015 , ... On July ... imposed by the FDA for nicotine laced liquid products. Their report says cigarette ... raised considerably. E-Cigarettes are particularly troublesome to addiction professionals as many of the ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 2Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 3Health News:Get More Organized with the Core Organizer App 2Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 2Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 3Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 4Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 5Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 6Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 2Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 3
... to ob/gyn specialty-specific ... patient care and practice management, MONTVALE, ... a leader in the field of obstetrics and,gynecological patient ... engine tool: OBGfindit.com (http://www.OBGfindit.com )., As part ...
... (April 25, 2008) -- Heart failure patients at NewYork-Presbyterian ... be implanted with the HeartMate II LVAS (Left Ventricular ... weak hearts pump blood -- that has now received ... broad use as bridge to transplantation. As part of ...
... May 2 With an aggressive growth plan in,effect ... has taken another big step in their expansion efforts ... Established in August of 2006, YoNaturals has maintained a ... and fast,growth they have experienced thus far is in ...
... 2 The Lupus Foundation of,America joins a coalition ... Lupus Day on May 10. More than 1.5 million,Americans ... unpredictable,future as they struggle daily with the often-debilitating health,consequences ... the result of an unbalanced immune system that can ...
... at the,mall and laser-hair removal offered at the neighborhood ... safe and effective procedures? The,future of Cosmetic Medicine will ... the American Society for Aesthetic Plastic Surgery,(ASAPS) being held ... Medicine: Embracing the Future" will be moderated by Robert,Singer, ...
... placement, SHANGHAI, China, May 2 /Xinhua-PRNewswire-FirstCall/ -- ... Bulletin Board: AAXT),today announced that, effective April 15, ... outstanding common stock of Asian Business,Management Group Limited, ... share exchange agreement. ATG acquired all of the ...
Cached Medicine News:Health News:OBGManagement.com and Convera(R) Launch Search Site for Physicians in the ObGyn Specialty 2Health News:FDA approves HeartMate II mechanical heart pump for heart-failure patients 2Health News:Gulfport-Biloxi Airport Welcomes Installation of New YoNaturals Healthy Vending Machines 2Health News:Lupus Organizations Issue International Call-to-Action to Combat Disease Affecting Five Million People 2Health News:Beauty for Life: The Future of Cosmetic Medicine 2Health News:Beauty for Life: The Future of Cosmetic Medicine 3Health News:Shanghai Medical Technology Co., Ltd. Completes Merger With Aamaxan Transport Group, Inc. 2Health News:Shanghai Medical Technology Co., Ltd. Completes Merger With Aamaxan Transport Group, Inc. 3Health News:Shanghai Medical Technology Co., Ltd. Completes Merger With Aamaxan Transport Group, Inc. 4
(Date:7/29/2015)... DUBLIN , July 27, 2015 ... the addition of the "Global Neurostimulation Devices ... The analysts forecast the global neurostimulation devices ... over the period 2014-2019. The report, ... based on an in-depth market analysis with inputs ...
(Date:7/29/2015)... -- ViaCyte, Inc., a privately-held regenerative medicine company with the first stem ... trials, today announced the opening of a second site in its ... T olerability, and E fficacy of VC-01™ Combination P ... is the first in Canada , will be ... , Alberta.  The lead Edmonton ...
(Date:7/29/2015)... 2015  Fifty groups representing 500,000 patients, doctors, and ... launch the AllTrials campaign in the US. The global ... future, to be registered and the results from it ... Goldacre explains: "Patients want the treatments that are ... what works. Unfortunately, we now know that around half ...
Breaking Medicine Technology:Global Neurostimulation Devices Market 2015-2019 2ViaCyte Announces Second Clinical Trial Site at University of Alberta 2ViaCyte Announces Second Clinical Trial Site at University of Alberta 3ViaCyte Announces Second Clinical Trial Site at University of Alberta 4Fixing Your Medicine: AllTrials Campaign Launches in US 2Fixing Your Medicine: AllTrials Campaign Launches in US 3
... , ATLANTA , Feb. ... Web site that provides healthcare professionals, patients, investors and the ... about Elekta,s solutions for treating cancer and brain disorders. ... offers increased functionality, including a new, clean design that appeals ...
... , NANTONG, ... Inc.,("Sinobiopharma" or, the "Company") (OTC Bulletin Board: SNBP) is ... Company,s flagship,product, KuTai (Cisatracurium Besylate), for coverage under National ... , KuTai (Cisatracurium Besylate), on ...
Cached Medicine Technology:Elekta Launches New Web Site for Global Health Care Community 2Elekta Launches New Web Site for Global Health Care Community 3China's Basic Medical Insurance to Cover Sinobiopharma's Flagship Product 2China's Basic Medical Insurance to Cover Sinobiopharma's Flagship Product 3
... Plate Capability The Equalizer 384 includes ... and equal tip spacing, choice of two software ... addition, this model allows you to evenly space ... accessing many gels and for use with 384 ...
... Exp Expandable Tip System A lower ... allows you to perform multi-sample transfers between two ... of a knob, tip spacing can be quickly ... tubes) or 96 well plates. Ergonomic Design ...
... Exp Expandable Tip System A ... System allows you to perform multi-sample transfers between ... pull of a knob, tip spacing can be ... microcentrifuge tubes) or 96 well plates. Ergonomic ...
... System A lower cost alternative to Equalizers, ... multi-sample transfers between two different vessel configurations. With ... spacing can be quickly and easily adjusted for ... plates. Ergonomic Design for Unparalleled Comfort ...
Medicine Products: